Inspection Record

Pfizer Inc. — Health Canada Inspection Findings

Health CanadaInspected 2022-02-07 4 findingsComputer system validationLaboratory and QC controlsDeviation, CAPA, and investigation

View the regulator's official source The source document is always the basis for judgement.

Findings

1Computer system validation

The calibration, inspection, and/or qualification of the equipment, including computerized systems, was inadequate.

2Laboratory and QC controls

The validation of test methods was inadequate.

3Laboratory and QC controls

The creation, maintenance, processing, and/or review of laboratory data was inadequate.

4Deviation, CAPA, and investigation

The investigation, handling, and/or reporting of test results that were out-of-specification was inadequate. Investigations into deviations, reports, and/or follow-up actions were inadequate.

About this record

Extracted automatically from the document of the Health Canada inspection on 2022-02-07. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Pfizer Inc. company profile — full history Health Canada documents, 2022 Go to Findings search